125 related articles for article (PubMed ID: 32107087)
1. Polymorphisms and rare variants identified by next-generation sequencing confer risk for lung cancer in han Chinese population.
Li X; Liu J; Wang K; Zhou J; Zhang H; Zhang M; Shi Y
Pathol Res Pract; 2020 Apr; 216(4):152873. PubMed ID: 32107087
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of Pathogenic Germline Mutations in Chinese Lung Cancer Patients through Next-Generation Sequencing.
Tian P; Cheng X; Zhao Z; Zhang Y; Bao C; Wang Y; Cai S; Ma G; Huang Y
Pathol Oncol Res; 2020 Jan; 26(1):109-114. PubMed ID: 31721094
[TBL] [Abstract][Full Text] [Related]
3. Association of PSMA4 polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.
Wang T; Chen T; Thakur A; Liang Y; Gao L; Zhang S; Tian Y; Jin T; Liu JJ; Chen M
Clin Transl Oncol; 2015 Jul; 17(7):564-9. PubMed ID: 25744645
[TBL] [Abstract][Full Text] [Related]
4. Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing.
Yu Z; Zhang Z; Liu J; Wu X; Fan X; Pang J; Bao H; Yin J; Wu X; Shao Y; Liu Z; Liu F
Mol Oncol; 2024 May; 18(5):1301-1315. PubMed ID: 37885353
[TBL] [Abstract][Full Text] [Related]
5. The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population.
Jiang C; Yu S; Qian P; Guo R; Zhang R; Ao Z; Li Q; Wu G; Chen Y; Li J; Wang C; Yao W; Xu J; Qian G; Ji F
Oncotarget; 2016 Sep; 7(37):59742-59753. PubMed ID: 27486757
[TBL] [Abstract][Full Text] [Related]
6. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
7. [DNA damage associated genetic variants contribute to lung cancer susceptibility in a Han Chinese population].
Li ZH; Wang YZ; Liu J; Zhu M; Du JB; Yuan J; Chen WH; Zhang ZD; Hu ZB; Wu TC; Shen HB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Aug; 50(8):721-7. PubMed ID: 27539526
[TBL] [Abstract][Full Text] [Related]
8. TERT-rs33963617 and CLPTM1L-rs77518573 reduce the risk of non-small cell lung cancer in Chinese population.
Ji Z; Li Y; Xiang C; Luo X; Yuan P; Long J; Shen N; Shen Y; Deng L; Li J; Cheng L
Gene; 2020 Mar; 731():144357. PubMed ID: 31935503
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Association of Eight Polymorphisms with Cancer Susceptibility in a Han Chinese Population.
Dong Y; Chen J; Chen Z; Tian C; Lu H; Ruan J; Yang W
PLoS One; 2015; 10(7):e0132797. PubMed ID: 26176862
[TBL] [Abstract][Full Text] [Related]
10. The Impact of
Zhuo M; Zhuang X; Tang W; Xu J; Zhang C; Qian X; Wang J; Liu H; Liu Y; Chen Z; Lin H
Biomed Res Int; 2018; 2018():8305745. PubMed ID: 30671474
[TBL] [Abstract][Full Text] [Related]
11. HapMap-based study on the association between MPO and GSTP1 gene polymorphisms and lung cancer susceptibility in Chinese Han population.
Gu JD; Hua F; Mei CR; Zheng DJ; Wang GF; Zhou QH
Acta Pharmacol Sin; 2014 May; 35(5):636-44. PubMed ID: 24786234
[TBL] [Abstract][Full Text] [Related]
12. Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.
Niu X; Chen Z; Shen S; Liu Y; Zhou D; Zhang J; Li Z; Yu Y; Liao M; Lu S; He L
J Thorac Oncol; 2010 May; 5(5):658-66. PubMed ID: 20234319
[TBL] [Abstract][Full Text] [Related]
13. Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population.
Fan L; Chen L; Ni X; Guo S; Zhou Y; Wang C; Zheng Y; Shen F; Kolluri VK; Muktiali M; Zhao Z; Wu J; Zhao D; He Z; Feng X; Yuan Z; Zhang J; Jin L; Wang J; Wang M
PLoS One; 2017; 12(4):e0175666. PubMed ID: 28410417
[TBL] [Abstract][Full Text] [Related]
14. Correlation of CLPTM1L polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.
Liang Y; Thakur A; Gao L; Wang T; Zhang S; Ren H; Meng J; Geng T; Jin T; Chen M
Tumour Biol; 2014 Dec; 35(12):12075-82. PubMed ID: 25155038
[TBL] [Abstract][Full Text] [Related]
15. Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation status.
Han L; Lee CK; Pang H; Chan HT; Lo IL; Lam SK; Cheong TH; Ho JC
Lung Cancer; 2017 Dec; 114():79-89. PubMed ID: 29173771
[TBL] [Abstract][Full Text] [Related]
16. Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.
Yang X; Wu J; Lu J; Liu G; Di G; Chen C; Hou Y; Sun M; Yang W; Xu X; Zhao Y; Hu X; Li D; Cao Z; Zhou X; Huang X; Liu Z; Chen H; Gu Y; Chi Y; Yan X; Han Q; Shen Z; Shao Z; Hu Z
PLoS One; 2015; 10(4):e0125571. PubMed ID: 25927356
[TBL] [Abstract][Full Text] [Related]
17. RTEL1 polymorphisms are associated with lung cancer risk in the Chinese Han population.
Yan S; Xia R; Jin T; Ren H; Yang H; Li J; Yan M; Zhu Y; Chen M
Oncotarget; 2016 Oct; 7(43):70475-70480. PubMed ID: 27765928
[TBL] [Abstract][Full Text] [Related]
18. COL6A3 polymorphisms were associated with lung cancer risk in a Chinese population.
Duan Y; Liu G; Sun Y; Wu J; Xiong Z; Jin T; Chen M
Respir Res; 2019 Jul; 20(1):143. PubMed ID: 31286980
[TBL] [Abstract][Full Text] [Related]
19. Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.
Li G; Guo X; Tang L; Chen M; Luo X; Peng L; Xu X; Wang S; Xiao Z; Yi W; Dai L; Wang J
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2011-2024. PubMed ID: 28664449
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.
Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D
Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
